SEC Form D · filed August 1, 2022
Mira1a Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
James Mcnulty, Cpa · Baltimore, MDExecAdam Kaplin, Md, Phd · Baltimore, MDExecDave Vorhoff · Baltimore, MDDirectorJude Uzonwanne · Baltimore, MDExecTalhia Tuck, Jd · Baltimore, MDDirectorPaul Rivard, Esq · Baltimore, MDExecChris Chapman, Md · Baltimore, MDDirectorBrad Kroenig · Baltimore, MDDirectorJosh Silverman · Baltimore, MDDirectorHugh Mccoll Iii · Baltimore, MDDirectorG. W. Carson · VANCOUVER, British Columbia, CanadaExecVera W. Kobalia · VANCOUVER, British Columbia, CanadaExecDarren E. Klinck · VANCOUVER, British Columbia, CanadaExecTimothy T. Barry · VANCOUVER, British Columbia, CanadaDirectorBrian D. Edgar · VANCOUVER, British Columbia, CanadaDirectorChristian J. Milau · VANCOUVER, British Columbia, CanadaDirectorEric Weisblum · Sarasota, FLExecKevin Munoz · Sarasota, FLDirectorJeff Pavell · Sarasota, FLDirectorWayne Linsley · Sarasota, FLDirectorJohn Banta · McLean, VAExecShannon K. Jagodinski · George Town, Grand Cayman, Cayman IslandsExecWhite Post Investments, LP · San Antonio, TXDirectorWhite Post Opportunity GP, LLC · San Antonio, TXDirectorChristopher Zarou · Garden City, NYExecSimon Cawdery · George Town, Cayman IslandsDirectorJeff Fox · Little Rock, ARDirectorNicholas Tuosto · Santa Monica, CADirectorPhilip Sanderson · Santa Monica, CADirectorDarin Myman · New Brunswick, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗